Investment Strategies
ESG and SRI Capabilities
Integrate environmental, social, and governance factors into your portfolio.
Align Your Portfolio With Your Vision For a Better Future
Make your mark on the world by integrating ESG and SRI investing criteria that incorporate your values and beliefs in your investments.
Access ongoing input on social investing issues and develop SRI policy guidelines with a team engaged in making a positive impact with our work.
Baseline SRI Restrictions
We have long maintained a baseline, firm-wide prohibition against the ownership of securities of companies engaged in the manufacture of distilled spirits, tobacco products, or weapons of mass destruction.
Data-Driven Research and Customization
By incorporating third-party and proprietary sources, we can produce portfolios that adhere to your strict ESG and SRI investing guidelines while seeking to meet your long-term goals.
One Size Does Not Fit All
Socially-responsible and ESG investments customized to reflect what matters most to you.
Responsible investment pairs your values with your long-term investment goals. Our long history of working with responsible investors helps us guide you through this process of alignment.
Partner With a UNPRI Signatory
Join a global network of investors committed to socially responsible investing and supporting a sustainable global financial system.
As signatories of the UN-supported Principles of Responsible Investment (UNPRI), we publicly commit to adopt and implement them, where consistent with our fiduciary responsibilities.
Make Your Impact with ESG and SRI Investing
Tailor your portfolio to reach your financial and value-driven goals.
Discover The Latest Insights
Stay up-to-date with reports and insights from our analysts and practice leaders.
2nd Quarter 2023: The Return of Guarded Optimism
Market Overview Last quarter began with markets still in the throes of the regional bank crisis following the March failures of Silicon Valley Bank and...
JAG Team Insights — Obesity Drug Craze Approaching Critical Milestone
June 2023 In recent years, a class of drugs known as GLP-1 agonists have experienced an unprecedented rise in popularity and captured the attention of...
JAG Team Insights — The AI Revolution: Key Takeaways from Quarterly Earnings Calls
June 2023 As we discussed in our Inaugural piece on AI, we believe the recent acceleration of Artificial Intelligence (AI) is the most disruptive development...